Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 52, Issue 2, Pages 216-221
Publisher
Springer Nature
Online
2016-09-19
DOI
10.1038/bmt.2016.213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation
- (2016) Timothy S. Fenske et al. BRITISH JOURNAL OF HAEMATOLOGY
- Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning
- (2015) A R Rezvani et al. BONE MARROW TRANSPLANTATION
- Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party
- (2015) S P Robinson et al. BONE MARROW TRANSPLANTATION
- Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study
- (2015) E Van Den Neste et al. BONE MARROW TRANSPLANTATION
- Emerging drugs for diffuse large B-cell lymphoma
- (2015) Patrizia Mondello et al. Expert Review of Anticancer Therapy
- Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review
- (2015) Rosalba Camicia et al. Molecular Cancer
- Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea–Japan collaborative study
- (2014) Ji-Won Kim et al. ANNALS OF HEMATOLOGY
- Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma
- (2014) I Avivi et al. BONE MARROW TRANSPLANTATION
- Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial
- (2014) Bertram Glass et al. LANCET ONCOLOGY
- Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era
- (2013) Sarah J. Nagle et al. AMERICAN JOURNAL OF HEMATOLOGY
- Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study
- (2013) Alba M. Redondo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study
- (2012) Luigi Rigacci et al. ANNALS OF HEMATOLOGY
- Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
- (2012) U. Bacher et al. BLOOD
- Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma
- (2012) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry
- (2011) Roel J.W. van Kampen et al. JOURNAL OF CLINICAL ONCOLOGY
- The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study
- (2011) Catherine Thieblemont et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Low Nonrelapse Mortality and Prolonged Long-Term Survival after Reduced-Intensity Allogeneic Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B Cell Lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire
- (2009) Anne Sirvent et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation
- (2008) M. R. Bishop et al. ANNALS OF ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started